Rakovina Therapeutics Secures Exclusive Access to Optimized KT-5000 Profile
An agreement gives Rakovina exclusive access to its optimized KT-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost.
An agreement gives Rakovina exclusive access to its optimized KT-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost.